BEATW (HeartBeam) Beginning Cash Position: $4.44 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BEATW HeartBeam Inc BEATW
26 GF Score
Price $0.14
! 2 Warning Signs
View Full Analysis

What is HeartBeam Beginning Cash Position?

HeartBeam BEATW 26 Beginning Cash Position is $4.44 Mil as of Mar. 2026. GuruFocus rates BEATW with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

HeartBeam's Beginning Cash Position for the quarter that ended in Mar. 2026 was $4.44 Mil.

HeartBeam's quarterly Beginning Cash Position declined from Sep. 2025 ($3.31 Mil) to Dec. 2025 ($1.91 Mil) but then increased from Dec. 2025 ($1.91 Mil) to Mar. 2026 ($4.44 Mil).

HeartBeam's annual Beginning Cash Position increased from Dec. 2023 ($3.59 Mil) to Dec. 2024 ($16.24 Mil) but then declined from Dec. 2024 ($16.24 Mil) to Dec. 2025 ($2.43 Mil).


HeartBeam Beginning Cash Position Related Terms


HeartBeam Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for HeartBeam's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartBeam Beginning Cash Position Chart

HeartBeam Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 0.02 13.19 3.59 16.24 2.43

HeartBeam Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 4.45 3.31 1.91 4.44
BEATW
26GF Score
HeartBeam Inc BEATW
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartBeam Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $4.44 Mil mean?
HeartBeam (BEATW) has a Beginning Cash Position of $4.44 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on HeartBeam and its competitors.
Is HeartBeam's Beginning Cash Position too high?
HeartBeam's current Beginning Cash Position is $4.44 Mil. Overall, HeartBeam has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does HeartBeam's Beginning Cash Position compare to CRVW and VASO?
HeartBeam's Beginning Cash Position of $4.44 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on HeartBeam and its competitors. HeartBeam's current Beginning Cash Position is $4.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartBeam stock overvalued right now?
HeartBeam (BEATW) has a current Beginning Cash Position of $4.44 Mil. The current Beginning Cash Position is $4.44 Mil. HeartBeam's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For HeartBeam (BEATW), the current Beginning Cash Position is $4.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartBeam Business Description

Other Exchanges BEAT:USA
Address 2118 Walsh Avenue, Suite 210, Santa Clara, CA, USA, 95050
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
26GF Score

Get the complete analysis for BEATW

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price